Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Shares, (euro)0.09 nominal value per share
-
Shares outstanding
-
75.4M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
26.7M
-
Shares change
-
+5.37M
-
Total reported value, excl. options
-
$558M
-
Value change
-
+$113M
-
Number of buys
-
39
-
Number of sells
-
-11
-
Price
-
$20.89
Significant Holders of Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) as of Q1 2021
61 filings reported holding MRUS - Merus N.V. - Common Shares, (euro)0.09 nominal value per share as of Q1 2021.
Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.7M shares
of 75.4M outstanding shares and own 35.43% of the company stock.
Largest 10 shareholders include BVF INC/IL (7.29M shares), FEDERATED HERMES, INC. (3.08M shares), BAKER BROS. ADVISORS LP (2.04M shares), BOXER CAPITAL, LLC (1.9M shares), WELLINGTON MANAGEMENT GROUP LLP (1.83M shares), Medicxi Ventures Management (Jersey) Ltd (1.6M shares), Sofinnova Investments, Inc. (1.31M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.11M shares), MPM Oncology Impact Management LP (701K shares), and Avoro Capital Advisors LLC (665K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.